Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens
about
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownDetection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patientsPhase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected SubjectsImmediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseDiversity in the acute CD8 T cell response to vaccinia virus in humans.Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.Recent progress in herpes simplex virus immunobiology and vaccine researchTherapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infectionDiversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.Human CD4+ CD25 high cells suppress proliferative memory lymphocyte responses to herpes simplex virus type 2.Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceDevelopment of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeHigh frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpesStable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAPFuture of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex VaccineCytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responsesExtensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptorDissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferonAdenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.Disulfide bonds of herpes simplex virus type 2 glycoprotein gB.ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans.Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes.CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.
P2860
Q21296712-93FEF151-D261-4BB1-A4E6-9236C625649DQ27485151-60195221-DA12-42A2-8DBC-3811ED4EEDCDQ27486108-6A73A447-2C3A-4768-B287-2D3573AA9872Q30442835-2DAEEDE5-446A-4928-8D4E-8513578B17AAQ33227607-51478779-83F3-4F83-B9AD-3541A76A51B3Q33785966-C83DD7C8-B6AE-4EFC-89AF-5F68264B2981Q33810277-E2E40AA2-8FEA-4D62-9BE1-52599EA1375DQ33893109-222BDC80-37AD-433D-A115-0EEB59AA13B9Q33963713-05A87BA2-A498-4301-A9AF-FCBF61783FAEQ34335569-221D59BE-8098-4AFB-8B28-59E0FFFF3FECQ34648449-838B0BEB-396B-4071-86E1-3A1C1A3BA77FQ35024021-0247770F-3CDB-448E-B5AF-A73F4E54D669Q35076638-FFB241D1-172C-4879-B80E-0F33092D0918Q35202180-FDBE47D8-F1AD-44C6-8B88-7F286612BD2CQ35699002-81AC99DB-58AA-49F9-ADE8-C5B9E99A2D00Q35871689-FC25F065-3C1A-4767-8E95-84879769D4EBQ35872807-73A85334-16CA-44C7-8A83-6DA750C97EEAQ35899978-7867FECF-741E-4471-A9B7-5BC70C615B42Q36025675-EC081058-6836-4132-891B-F95A3D8EE8BDQ36363678-951FA155-2275-4735-8495-B6D39D02B0E1Q36585733-86EB5703-FB26-42BF-AB5F-8DBF39A12BA7Q36601101-55B823BC-168F-42BF-B1D7-CD6289E025A4Q36626491-9FAEC0E2-8319-40D0-82CC-1E385A7A783CQ36633084-F0104B81-71AD-48A8-A6D1-FD86C4624D89Q36689912-3386D505-3C2B-4417-BA33-F2F843114CDDQ36871818-2B50AB6C-20DC-49C9-82F1-A2F77F80F0ECQ36974311-6FA3B187-69FD-41B6-8418-08D450EE94BBQ37380356-BAA9D6D5-ECD3-4F35-A2D0-A6494C6B79C3Q39868823-641667C5-3FEF-41B7-BAA2-FDACC6D8AF23Q39876176-B3CD2239-3C4B-4256-A2BC-53C8C7D324D9Q39876405-5483D6B6-D106-46FB-8868-15FC22F11779Q39876716-58F16803-9A1E-4D5D-893E-E71C7686A91CQ41848044-EE777C9B-2786-40C0-8DCF-0CB755FA57ACQ41879095-BFDD09D0-E476-406E-BF0E-B4F34384767BQ42282904-B6E287B4-9B6F-4C15-BEA5-2365EB81F32C
P2860
Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@ast
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@en
type
label
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@ast
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@en
prefLabel
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@ast
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@en
P2093
P2860
P1433
P1476
Human CD8+ herpes simplex viru ...... iverse virion protein antigens
@en
P2093
P2860
P304
P407
P577
1992-03-01T00:00:00Z